ZMZachary P. Morehouse

Zachary P. Morehouse

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Zachary P. Morehouse has a total of 58 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Prevalence and cardiac outcomes of T wave inversions in high school athletes: an analysis of 15 years of preparticipation screening ECGs

    by Zachary P Morehouse, Dermot M Phelan, David E Price

    Objective: To characterise the prevalence, distribution pattern and clinical relevance of T wave inversion (TWI) on a screening preparticipation 12-lead ECG in high school athletes. Methods: A retrospective cohort study analysed ECGs from athletes screened between 2010 and 2025 during a preparticipation event. Athletes with TWI in ≥2 contiguous leads were included. Longitudinal cardiac outcomes were assessed via electronic health records, semistructured interviews and extensive media and death registries review. Results: Among 16 893 high school athletes screened (mean age 15.3±1.1 years), 61 (0.36%) demonstrated TWI in ≥2 consecutive leads, representing 20.2% of those flagged with abnormal ECGs. The majority of athletes with TWI were male (n=51, 83.6%), with 46 (75.4%) in black and 14 (23.0%) in non-black male athletes. Anterior+lateral + inferior TWI was the most frequent pattern (n=17, 27.9%). Four male athletes were identified with confirmed or presumed hypertrophic cardiomyopathy (HCM); two identified after screening, one identified 5 years after screening and one lost to follow-up who did not complete the diagnostic evaluation until after a cardiac arrest 2 years later. Conclusion: Abnormal TWI was rare in this large US adolescent athlete cohort, with higher prevalence among black males. All confirmed or presumed cases of HCM occurred in athletes with inferior+lateral TWI, underscoring the importance of a comprehensive assessment and longitudinal surveillance in athletes with this ECG phenotype.

  • Open Access

    Improved sample preparation using bead mill homogenization

    by Madison E. Walbrun, Aamna Aijaz, Gabriella Ryan, John D. Bunting, Zachary P. Morehouse, Rodney J. Nash


  • Problematic Pharmacokinetics: A Case of Recurrent Pancreatitis Post Discontinuation of a Glucagon-Like Peptide 1 Receptor Agonists

    by Zachary P. Morehouse, Jack D. Ledford

    Glucagon-like peptide 1 receptor agonists (GLP-1RA) are guideline recommended agents for the treatment of type 2 diabetes mellitus (T2DM) and select agents (liraglutide and semaglutide) are FDA approved as anti-obesity pharmacotherapy options. These drugs act on the incretin hormone system within the body to revive insulin excretion, delay gastric emptying, and inhibit the production of glucagon from pancreatic alpha cells. Acute pancreatitis is a serious condition that may have a fatal outcome. It has been shown, and is now part of the prescribing information label, that GLP-1RA agents can cause changes in the pancreas that may ultimately lead to pancreatitis. We describe the case of a 53-year-old female patient with uncontrolled type II diabetes mellitus, who experienced multiple episodes of pancreatitis, from what we suspect was due to repeated exposure to the GLP-1 RA agent, semaglutide. After discontinuation of semaglutide, our patient experienced another episode of pancreatitis roughly 15-week later; which we believe may be due to the patient experiencing the effects of a smoldering pancreas brought on by repeated injury and prolonged circulation of semaglutide post-discontinuation.


  • Open Access

    A narrative review of nine commercial point of care influenza tests: an overview of methods, benefits, and drawbacks to rapid influenza diagnostic testing

    by Zachary P. Morehouse, Nathan Chance, Gabriella L. Ryan, Caleb M. Proctor, Rodney J. Nash

    Context: Rapid influenza diagnostic tests (RIDTs) are becoming increasingly accurate, available, and reliable as the first line of testing when suspecting influenza infections, although the global burden of influenza infections remains high. Rapid diagnosis of influenza infections has been shown to reduce improper or delayed treatment and to increase access to diagnostic measures in public health, primary care, and hospital-based settings. Objectives: As the use of RIDTs continues to expand in all healthcare settings, there is a multitude of molecular techniques being employed by these various testing platforms. With this in mind, we compare the sensitivity, specificity, and time to diagnosis for nine highly utilized commercial RIDTs. Methods: Nine commercially available RIDTs were identified from the US Centers for Disease Control and Prevention (CDC) website, which were also referenced on PubMed by name within the title or abstract of peer-reviewed publications examining the sensitivity and specificity of each test against a minimum of three influenza A virus (IAV) strains as well as seasonal influenza B virus (IBV). Data from the peer-reviewed publications and manufacturers’ websites were combined to discuss the sensitivity, specify, and time to diagnosis associated with each RIDT. Results: The sensitivity and specificity across the examined RIDTs were greater than 85.0% for both IAV and IBV across all platforms, with the reverse transcriptase–polymerase chain reaction (RT-PCR) assays maintaining sensitivity and specificity greater than 95.0% for all viruses tested. However, the RT-PCR platforms were the longest in time to diagnosis when compared to the other molecular methods utilized in the examined RIDTs. Conclusions: Herein, we discussed the benefits and limitations of nine commercially available RIDTs and the molecular techniques upon which they are based, showing the relative accuracy and speed of each test for IAV and IBV detection as reported by the peer-reviewed literature and commercial manufacturers.


  • Open Access

    Comparison of mechanical homogenization versus enzymatic digestion sample preparation methodologies for SARS-CoV-2 detection in saliva for surveillance of variants of concern on the University of Tennessee campus in early 2021

    by Magen R. Poindexter, Tingting Xu, Cynthia M. Swift, Caleb M Proctor, Fadime Kara-Murdoch, Zachary P Morehouse, Gabriella L Ryan, Frank E. Löffler, Rodney J Nash

    The SARS-CoV-2 pandemic has profoundly impacted communities across the globe, requiring accurate and accessible diagnostic technologies in support of public health mitigation efforts. As testing has evolved throughout the course of the pandemic, varying sample preparation methodologies have been employed. Herein we perform a comparison of three commercial sample preparation methods: two mechanical homogenization workflows and one enzymatic digestion approach for the detection of SARS-CoV-2 from biomarker genes in 20 human saliva pools. SARS-CoV-2 variants of concern were also identified on the University of Tennessee, Knoxville campus during the spring semester of 2021 utilizing the commercial PerkinElmer PKamp VariantDetect SARS-CoV-2 RT-PCR Assay kit. Two hundred and ten (210) human saliva pools were selected and analyzed for the presence of SARS-CoV-2 variants of concern providing insight into the utility of these various commercial workflows for integration into current public health SARS-CoV-2 surveillance measures.

  • A Novel PCR-Based Methodology for Viral Detection Utilizing Mechanical Homogenization

    by Zachary P. Morehouse, Caleb M. Proctor, Gabriella L. Ryan, Rodney J. Nash

    The impact of viral diseases on human health is becoming increasingly prevalent globally with the burden of disease being shared between resource-rich and poor areas. As seen in the global pandemic caused by SARS-CoV-2, there is a need to establish viral detection techniques applicable to resource-limited areas that provide sensitive and specific testing with a logistically conscious mindset. Herein, we describe a direct-to-PCR technology utilizing mechanical homogenization prior to viral PCR detection, which allows the user to bypass traditional RNA extraction techniques for accurate detection of human coronavirus. This methodology was validated in vitro, utilizing human coronavirus 229E (HCoV-229E), and then clinically, utilizing patient samples to test for SARS-CoV-2 infection. In this manuscript, we describe in detail the protocol utilized to determine the limit of detection for this methodology with in vitro testing of HCoV-229E., [摘要]病毒性疾病对人类健康的影响在全球范围内日益普遍,疾病负担在资源丰富地区和贫困地区之间分担。从 SARS-CoV-2 引起的全球大流行中可以看出,需要建立适用于资源有限地区的病毒检测技术,以具有后勤意识的思维方式提供敏感和特定的检测。在此,我们描述了一种在病毒 PCR 检测之前利用机械均质化的直接 PCR 技术,该技术允许用户绕过传统的 RNA 提取技术来准确检测人类冠状病毒。该方法在体外使用人类冠状病毒 229E (HCoV-229E) 进行了验证,然后在临床上使用患者样本测试 SARS-CoV-2 感染。在这份手稿中,我们详细描述了用于确定该方法的检测限的协议,并通过 HCoV-229E的体外测试。[背景] 基于聚合酶链式反应 (PCR) 和逆转录酶 PCR (RT-qPCR) 的方法是目前检测人类病毒感染的主要方法 ( Elnifro 等人,2000)。这些 PCR 方法通常依赖于多个化学提取步骤,用于从临床样本中裂解病毒颗粒,然后进行一系列洗涤步骤,这些步骤旨在纯化暴露的病毒遗传物质,同时去除其他大分子,例如碳水化合物和蛋白质,这可能会影响下游分子应用( Elnifro 等人,2000)。分离纯化的遗传物质后,将其放入 PCR 混合物中以检测特定的目标基因序列,从而验证病毒的存在。这种用于病毒PCR检测的传统提取模型在确认感染方面具有高度敏感性和特异性( Elnifro 等人,2000)。然而,正如在 SARS-CoV-2 引起的全球大流行中所看到的那样,压力重重的全球供应链无法始终确保这些提取所需的化学试剂的可用性,从而推动了对新型诊断技术的需求( Bustin 等人,2020)。 在这里,我们描述了一种方法,其中机械均质化用于裂解病毒颗粒,当直接放入 PCR 时暴露 RNA 以准确检测病毒,无需进行进一步的提取步骤或化学洗涤(Morehouse等人,2020)。据报道,该方法利用人类冠状病毒 229E (HCoV-229E) 对临床病毒样本进行体外模拟(Morehouse等人,2020 年),以及使用鼻咽和口咽拭子进行检测的现场验证研究来自患者的 SARS-CoV-2(Morehouse等人,2021 年)。这种基于均质化的直接 PCR 技术允许对人类冠状病毒进行准确的病毒检测,而不需要传统上用于 RT-qPCR 检测工作流程的耗时且昂贵的化学提取技术(Morehouse等人,2020 年)。 为了改善获得具有成本效益的诊断解决方案的机会,我们展示了如何以与当前基于金标准提取的技术相似的敏感性和特异性在临床浓度下准确检测人类冠状病毒(Morehouse等人,2020 和 Morehouse等人。 , 2021)。至关重要的是,不断开发诸如此类的创新诊断解决方案,以应对在资源有限的环境中提供准确病毒检测的后勤挑战。通过利用机械均质化,我们能够从尖刺拭子中检测 HCoV-229E,模拟鼻咽拭子上临床相关的病毒浓度,作为该技术的初步概念验证研究(Morehouse等人,2021 年)。在后来的研究中,基于均质化的直接 PCR 方法通过患者样本筛查 SARS-CoV-2 得到了进一步验证(Morehouse等人,2021 年)。在这份手稿中,我们列出了在我们基于均质化的直接 PCR 技术的初始概念验证测试中使用的详细协议,利用带有尖刺 HCoV-229E 的模拟鼻咽拭子来确定该方法的检测限。

  • Open Access

    Embracing industry sponsored research to expand osteopathic medical student research experiences

    by Zachary P. Morehouse, Rodney J. Nash

    Article Embracing industry sponsored research to expand osteopathic medical student research experiences was published on September 2, 2021 in the journal Journal of Osteopathic Medicine (volume 0, issue 0).

  • Open Access

    A Rare Variant of Guillain-Barre Syndrome Following Ad26.COV2.S Vaccination

    by Zachary P. Morehouse, Amanda Paulus, Sri A Jasti, Xue Bing

    Efforts to combat the global pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) range from adequate diagnostic testing and contract tracing to vaccination for the prevention of coronavirus disease 2019 (COVID-19). In the United States alone, three vaccinations have been authorized for emergency use (EUA) or approved to prevent COVID-19. The Ad26.COV2.S vaccine by Johnson and Johnson (New Brunswick, New Jersey) is the only adenovirus-based vaccine and deemed relatively effective and safe by the US Food and Drug Administration (FDA) following its clinical trial. Since its introduction, the US FDA has placed a warning on the vaccine adverse event reporting system (VAERS) after more than 100 cases of Guillain-Barre Syndrome (GBS) were reported. Herein, we outline the hospital course of a generally healthy 49-year-old female who experienced an axonal form of GBS nine days after receiving the Ad26.COV2.S vaccine.


  • Open Access

    Validation of a direct-to-PCR COVID-19 detection protocol utilizing mechanical homogenization: A model for reducing resources needed for accurate testing

    by Zachary P. Morehouse, Lyson Samikwa, Caleb M. Proctor, Harry Meleke, Mercy Kamdolozi, Gabriella L. Ryan, David Chaima, Antonia Ho, Rodney J. Nash, Tonney S. Nyirenda

    Efficient and effective viral detection methodologies are a critical piece in the global response to COVID-19, with PCR-based nasopharyngeal and oropharyngeal swab testing serving as the current gold standard. With over 100 million confirmed cases globally, the supply chains supporting these PCR testing efforts are under a tremendous amount of stress, driving the need for innovative and accurate diagnostic solutions. Herein, the utility of a direct-to-PCR method of SARS-CoV-2 detection grounded in mechanical homogenization is examined for reducing resources needed for testing while maintaining a comparable sensitivity to the current gold standard workflow of nasopharyngeal and oropharyngeal swab testing. In a head-to-head comparison of 30 patient samples, this initial clinical validation study of the proposed homogenization-based workflow demonstrated significant agreeability with the current extraction-based method utilized while cutting the total resources needed in half.


  • Open Access

    A proposed method of sample preparation and homogenization of hemp for the molecular analysis of cannabinoids

    by Zachary P. Morehouse, Gabriella L. Ryan, Caleb M. Proctor, Akelachi Okparanta, Will Todd, Derrick Bunting, Taylor White, Steven Parez, Blessida Miller, Veronica Colon, et al.

    The use of Cannabis sativa, or Hemp, in commercial, recreational, and pharmacological applications is on the rise in the United States and worldwide. Many of these applications have guidelines associated with them dependent on the concentration of cannabinoid molecules that keep the products classified as hemp versus marijuana or that allow the producer to comment on the purity and potency of their product. Herein, we propose a method for homogenization of hemp that results in small particle sizes, uniform samples, and does not alter the cannabinoid concentrations during processing, allowing for optimal and reproducible potency testing. Using a novel “active grinding media” we homogenized commercially available hemp to analyze approximately 100 mg samples of homogenate via sieve analysis and high-performance liquid chromatography to assess the resulting size and potency of the sample when using this methodology. When processing hemp samples with our proposed methodology, we have demonstrated the ability to produce 60.2% of all particles < 1.25 mm with increased cannabinoid recovery compared to homogenates with larger average particle sizes. Maintaining sample temperatures below 35 °C during processing, we showed that our method does not thermally induce decarboxylation reactions that would result in major cannabinoid profile changes. We have developed a method for hemp processing via homogenization that does not alter the cannabinoid profile during processing, while consistently producing small particle sizes in a uniformly processed sample. This method allows for optimal and reproducible hemp processing when evaluating hemp and hemp-based products being brought to commercial markets.